C4 Therapeutics Inc.

07/16/2024 | Press release | Distributed by Public on 07/16/2024 22:12

C4 Therapeutics to Present Preliminary Monotherapy Data from the Ongoing Phase 1 Trial of CFT1946 as a Mini Oral Presentation at the ESMO Congress 2024

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.